|
|
Single Dose Study of the Safety and Efficacy of AGN-150998 in Patients with Exudatice Age-related Macular Degeneration"
| Third-party funded project |
| Project title |
Single Dose Study of the Safety and Efficacy of AGN-150998 in
Patients with Exudatice Age-related Macular Degeneration" |
| Principal Investigator(s) |
Prünte, Christian
|
| Organisation / Research unit |
Bereich Spezialfächer (Klinik) / Ophthalmologie USB |
| Project start |
01.03.2012 |
| Probable end |
28.02.2013 |
| Status |
Completed |
| Abstract |
Fördergeber: Allergan Limited, England, 1st Floor, Marlow International, Parkway, Marlow Buckinghamshire SL7 1YL, UK
(Single Dose Study of the Safety and Efficacy of AGN-150998 in Patients with Exudatice Age-related Macular Degeneration")
Keine Fördergelder von Basel! |
| Financed by |
Other sources
|
| |
|
|
MCSS v5.8 PRO. 0.660 sec, queries - 0.000 sec
©Universität Basel | Impressum
|  |
|
05/05/2024
Research Database / FORSCHUNGSDATENBANK
|
